The FDA has approved Gvoke VialDx (glucagon) for IV use as a diagnostic aid during radiologic examinations to temporarily inhibit movement of the GI tract.
Bright Uro announced today that it has received FDA 510(k) clearance for its Glean urodynamic analyzer system.
The Visby Medical Women's Sexual Health Test received marketing authorization to diagnose chlamydia, gonorrhea, and trichomoniasis in women.
MyChesCo on MSN3d
FDA Unveils Key Updates on Rare Disease Advances, Food Safety, and Medical InnovationsThe U.S. Food and Drug Administration (FDA) has released a series of announcements covering a wide range of initiatives and ...
Health on MSN5d
FDA Says Ozempic Is No Longer in Shortage—Does That Mean the End of Cheaper Copycat Versions?Fact checked by Nick Blackmer Compounded versions of semaglutide, the active ingredient in weight loss drugs like Ozempic and ...
Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...
Vasorum USA, Inc. announced FDA approval of the Celt ACD Plus system, which is designed for rapid arterial puncture closure ...
CHICAGO -- Coming this weekend, the American College of Cardiology (ACC) annual conference will feature research exploring ...
A remote monitoring program predicted when patients with asthma would experience distress, according to a poster presented at ...
Each year, millions of people in America are prescribed a medicine for acute pain.Now, for the first time in over 20 years, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback